Polymers for Extrusion-Based 3D Printing of Pharmaceuticals: A Holistic Materials–Process Perspective
Open accessThe DOI matches its Crossref record; 172 of the 176 references it cites were found in a registry or an index.
Abstract
Three dimensional (3D) printing as an advanced manufacturing technology is progressing to be established in the pharmaceutical industry to overcome the traditional manufacturing regime of 'one size fits for all'. Using 3D printing, it is possible to design and develop complex dosage forms that can be suitable for tuning drug release. Polymers are the key materials that are necessary for 3D printing. Among all 3D printing processes, extrusion-based (both fused deposition modeling (FDM) and pressure-assisted microsyringe (PAM)) 3D printing is well researched for pharmaceutical manufacturing. It is important to understand which polymers are suitable for extrusion-based 3D printing of pharmaceuticals and how their properties, as well as the behavior of polymer–active pharmaceutical ingredient (API) combinations, impact the printing process. Especially, understanding the rheology of the polymer and API–polymer mixtures is necessary for successful 3D printing of dosage forms or printed structures. This review has summarized a holistic materials–process perspective for polymers on extrusion-based 3D printing. The main focus herein will be both FDM and PAM 3D printing processes. It elaborates the discussion on the comparison of 3D printing with the traditional direct compression process, the necessity of rheology, and the characterization techniques required for the printed structure, drug, and excipients. The current technological challenges, regulatory aspects, and the direction toward which the technology is moving, especially for personalized pharmaceuticals and multi-drug printing, are also briefly discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![Figure 7 Viscosity ratio (η/ηo) of acetaminophen (APAP) in poly (ethylene oxide) (PEO) at different temperatures to determine the solubility of the drug. Reprinted with permission from M Yang, International Journal of Pharmaceutics, Published by Elsevier, 2011 [123].](https://figures.cochat.ai/paper-figures/5b0f2d6634994ae79cc2c2cbcb3eb075/polymers-for-extrusion-based-3d-printing-of-pharmaceuticals-a-holistic-figure-7.jpg)
![Figure 8 The rheological characterization of the blends of different polymers [Affinisol 15LV (Aff15), Kollidon SR (KollSR), Eudragit EPO (EPO), hydroxypropyl cellulose (HPC)]. Constituent effect visualized with frequency sweep at the maximum processing temperature (200 °C). Reprinted with permission from K Ilyés, European Journal of Pharmaceutical Sciences, Published by Elsevier, 2019 [136].](https://figures.cochat.ai/paper-figures/b1ca4ae8602d4e64bbc6cbb3bfa0f28d/polymers-for-extrusion-based-3d-printing-of-pharmaceuticals-a-holistic-figure-8.jpg)

![Figure 10 (a) Design of tablets, (b) the relationship between the target and achieved prednisolone dose, and (c) PVA based FDM 3D printed tablets having different dose strengths [56].](https://figures.cochat.ai/paper-figures/76d1606acd2449ce8e030af1e4501a72/polymers-for-extrusion-based-3d-printing-of-pharmaceuticals-a-holistic-figure-10.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“3D printing enables the fabrication of complex three-dimensional structures via computer-aided design, allows precise control over scaffold porosity, pore size, and microstructure, and facilitates accurate modulation of mechanical strength, and creates microstructures with graded porosity within a single scaffold [88–90].”
From Application of PLCL as a biodegradable polymer in biomedical engineering (2026) · cites this paper as [88]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polymers for 3D Printing and Customized Additive Manufacturing
Ligon, S. C., Liska, R., Stampfl, J., Gurr, M., & Mülhaupt, R. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00074 · Cited by 3,741
Farah, S., Anderson, D. G., & Langer, R. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.012 · Cited by 3,443
Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)
Siepmann, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00112-0 · Cited by 2,613
Biomedical applications of biodegradable polymers
Ulery, B. D., Nair, L. S., & Laurencin, C. T. (2011) · Journal of Polymer Science Part B: Polymer Physics · doi:10.1002/polb.22259 · Cited by 2,206
Correlation of dynamic and steady flow viscosities
Cox, W. P., & Merz, E. H. (1958) · Journal of Polymer Science · doi:10.1002/pol.1958.1202811812 · Cited by 2,092
Personalized medicine: Time for one-person trials
Schork, N. J. (2015) · Nature · doi:10.1038/520609a · Cited by 1,223
Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)
Siepmann, J., & Peppas, N. A. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.028 · Cited by 1,021
Awaja, F., Gilbert, M., Kelly, G., Fox, B., & Pigram, P. J. (2009) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2009.04.007 · Cited by 928
Three-Dimensional Printing: Rapid Tooling and Prototypes Directly from a CAD Model
Sachs, E., Cima, M., & Cornie, J. (1990) · CIRP Annals · doi:10.1016/s0007-8506(07)61035-x · Cited by 871
A new chapter in pharmaceutical manufacturing: 3D-printed drug products
Norman, J., Madurawe, R. D., Moore, C. M. V., Khan, M. A., & Khairuzzaman, A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.001 · Cited by 810
Research works printed but not linked: 3
- 107. Hardung H., Djuric D., Ali S. Combining HME & solubilization: Soluplus®—The solid solution. Drug Deliv. Technol. 2010;10:20–27.
- 134. Aho J., Genina N., Edinger M., Botker J.P., Baldursdottir S., Rantanen J. Drug-loaded poly (ε-caprolactone) for 3D printing of personalized medicine: A rheological study; Proceedings of the 25th Nordic Rheology Conference; Helsinki, Finland. 30 May–1 June 2016; pp. 97–100.
- 164. Campbell R. Pharma to table: 3-D printing and the regulatory future of home remedies. Conn. L. Rev. CONNtemplations. 2017;49:1.
Cited by
Items 301–355 of 355
3D and 4D Technology for Pharmaceutical Drug Delivery: A Detailed Insight
Soni, S., Yadav, V., Kumar, D., & Tiwari, S. K. (2024) · Drug Delivery Letters · doi:10.2174/0122103031312257241011071610 · Cited by 2
Gavarić, N., Todorović, N., Popović, S. Z., Božić, I., Vojnović, A., Milošević, N., & Lalic-Popovic, M. N. (2025) · Chemosensors · doi:10.3390/chemosensors13120417 · Cited by 1
“…of both the polymer and active ingredient, molecular interactions between polymer and drug, as well as the hydrophilic/hydrophobic balance and pH responsiveness of the matrix, are critical considerations when selecting materials and assessing the feasibility of a specific formulation [19,20].”
[Research progress on three-dimensional printed interbody fusion cage].
Gou, C., Zhang, Y., Nie, G., He, Y., & Guan, T. (2021) · PubMed Central · doi:10.7507/1001-5515.202104066 · Cited by 1
Farcas, M. T. (2021) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.8106 · Cited by 1
Additive Manufacturing Techniques for Drug Delivery Applications
Panda, S., Deshmukh, K., Karthik, T. V. K., & Pasha, S. K. (2022) · Wiley eBooks · doi:10.1002/9783527835478.ch17 · Cited by 1
Regulatory Aspects of 3D‐Printed Medicinal Products
Malamatari, M., Wan, K., & Baxevanis, F. (2024) · doi:10.1002/9781119836001.ch11 · Cited by 1
Personalized Medicine with 3D Printing
Malviya, R., & Sharma, R. (2024) · Wiley eBooks · doi:10.1002/9781394234233.ch8 · Cited by 1
Panaite, C. E., Mihalache, A. M., Dodun, O., Slătineanu, L., Popescu, A., Hrițuc, A., & Nagîț, G. (2022) · Polymers · doi:10.3390/polym14091714
Hopson, P. L. (2022) · ASM International eBooks · doi:10.31399/asm.hb.v23a.a0006900 · Cited by 1
The role of control in achieving flexible and sustainable pharmaceutical manufacturing
Copoţ, D., Ghita, M., & Birs, I. (2022) · IEEE Conference on Control Technology and Applications (CCTA) · doi:10.1109/ccta49430.2022.9966130
“Material properties such as viscosity, density, porosity, viscoelastic properties are key factors in order to obtain the optimal composition for tablet production [15].”
BackgroundTagami, T., Ogawa, K., & Ozeki, T. (2022) · Drug Delivery System · doi:10.2745/dds.37.294
A Research Status of 3D Printing of Different Metal Forms
Liu, J., Li, Y., Fan, J., Wu, S., Li, Y., & Wang, J. (2023) · Lecture notes on data engineering and communications technologies · doi:10.1007/978-3-031-28893-7_45
Printability of Pharmaceutical Polymers: Issues and Solutions
Tomuță, I., & Porfire, A. S. (2023) · AAPS introductions in the pharmaceutical sciences · doi:10.1007/978-3-031-34119-9_4
Baran, E., Birczyński, A., Dorożyński, P., & Kulinowski, P. (2023) · Macedonian Pharmaceutical Bulletin · doi:10.33320/maced.pharm.bull.2023.69.03.047
“The use of three-dimensional (3D) printing (additive manufacturing technology) in pharmacies could enable the production of patient-tailored batches of dosage forms with different dosing and release characteristics (Azad et al., 2020; Trenfield et al., 2018).”
BackgroundResearch Progress and Challenges of 3D Printed Conductive Biological Scaffolds
Li, W., Guangming, Z., Zun, Y., Zhifeng, H., Lingxuan, M., Zilong, P., Miao, X., Lin, X., Xi, Y., & Hongbo, L. (2023) · Journal of Mechanical Engineering · doi:10.3901/jme.2023.23.186 · Cited by 1
Analytical Characterisation of 3D‐Printed Medicines
Lima, A. L., Barreto, L. C. L. D. S., & Filho, M. C. (2024) · Wiley eBooks · doi:10.1002/9781119836001.ch8
McDonagh, T., Zhang, B., & Qi, S. (2024) · Wiley eBooks · doi:10.1002/9781119836001.ch1
Li, A., Zhang, K., Wang, Z., Liu, S., Li, X., Ren, J., Zhang, J., Shi, Y., Gao, Y., Qian, S., et al. (2024) · Advanced Materials Technologies · doi:10.1002/admt.202400840
Effect of 3-D printing on the production on solid dosage forms in pharmaceutical industry
Yenurkar, Y. N., Khobragade, D. S., & BHANGE, M. A. (2024) · AIP conference proceedings · doi:10.1063/5.0240353
CNC Assisted Extrusion-Based 3D Printing of EVA Graphene Composite
Bajpai, A., & Jain, P. K. (2025) · Lecture notes in mechanical engineering · doi:10.1007/978-981-96-3165-0_27
Vimon, S., Romyasamit, C., Chanpakdee, R., Boonplu, S., Nuengjamnong, C., Makkliang, F., Sangkanu, S., Nissapatorn, V., Saengsawang, P., Dalgaard, T. S., et al. (2025) · South African Journal of Botany · doi:10.1016/j.sajb.2025.06.041 · Cited by 1
Extrusion-Based 3D Printing of Rutin Using Aqueous Polyethylene Oxide Gel Inks
Коshovyi, O., Heinämäki, J., Shpychak, A. O., Meos, A., Topelius, N. S., & Raal, A. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17070878
“Therefore, 3D printing technologies are interesting and promising techniques for preparing novel types of personalised dosage forms for flavonoids [22,23].”
Formas, K., Janusz, J., Kurowska, A., Benko, A., Piekarczyk, W., & Rajzer, I. (2025) · Materials · doi:10.3390/ma18133192
“The polymer filament is loaded into a printer, melted, and then extruded to form a desired shape, layer by layer [4–6].”
Abouelmajd, M., Khadiri, I. E., Ezzaraa, I., Zemzami, M., Arroub, I., Bahlaoui, A., Lagache, M., & Belhouideg, S. (2024) · International Conference on Connected Innovation and Technology (ICCITX) · doi:10.1109/iccitx61791.2024.11070391
“This process is instrumental in the creation of customized medical devices, prosthetics, and anatomical models, contributing significantly to the evolution of healthcare solutions [4].”
21. Yüzyılda Yapay Zekâ Destekli 3D Baskı Teknolojisinin Heykel Alanındaki İşlevsel Dönüşümü
Özdal, M. A. (2025) · Mentor · doi:10.64293/mentor.v1i2.15
Advances in Active Pharmaceutical Ingredient (API) Incorporation into 3D-Printed Dosage Forms
Kar, K., Chowdhury, S., & Chakraborty, P. (2025) · Springer eBooks · doi:10.1007/978-981-96-9075-6_6
Goudarzi, A., Karami, T., MOHAMMAD, H. A., Akrami, M., Mohammadi, S., & Haririan, I. (2025) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2025.2573673
Goudarzi, A., Salehi, Z., Akrami, M., Haririan, I., & Sajedi, R. H. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126344
Pereira, A., Moetazedian, A., Taylor, M. J., Longbottom, F. E., Ghazal, H. S., Han, J., & Zhang, B. (2026) · Journal of Manufacturing and Materials Processing · doi:10.3390/jmmp10010039
Brahma, R., Boruah, B., Khatun, L., & Ray, S. (2026) · Springer series on polymer and composite materials · doi:10.1007/978-3-032-16034-8_9
Althobaiti, A. A. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-10557-3
“The Chronotopic™ System One of the most illustrative examples of FDM-based chronotherapy is the Chrono-topic™ system developed by Melocchi et al.[25, 26] This based on relevance, scientific quality, and contribution to understanding the capabilities, limitations, and translational challenges of…”
Kozakiewicz-Latała, M., Krzaczkowski, P., Śnietura, W., Brożyna, J., Czapor‐Irzabek, H., Brożyna, M., Malec, K., & Karolewicz, B. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126930
ADDITIVE TECHNIQUES AND BIOPRINTERS IN PHARMACEUTICAL INDUSTRY: A REVIEW OF MODERN APPLICATIONS
Koval, V. M., Hutsol, V. V., Kryvoviaz, O. V., Tomashevska, Y. O., VOITENKO, T., Toziuk, O., & Крамар, Г. І. (2026) · Здобутки клінічної і експериментальної медицини · doi:10.11603/1811-2471.2026.v.i1.16128
Kshatri, T., Parashar, R., Dubey, S. K., & Suresh, P. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36751-9.00019-x
Barar, J., Fiano, K. S., Seamon, M. J., Albensi, B. C., Khanfar, N. M., & Omidi, Y. (2026) · Bioimpacts · doi:10.34172/bi.33047
“110 Moreover, the introduction of such technologies aligns with the broader push toward patient-centric care.”
2 Role of Rheology in Advanced Polymer Processing
Ray, S. S., Banerjee, R., Bandyopadhyay, J., & Orasugh, J. T. (2024) · Carl Hanser Verlag GmbH & Co. KG eBooks · doi:10.1007/978-1-56990-327-8_2
Ćoškov, A., Todorović, N., Čupić, M. B., Vranka, M., Jolić, L., Milosevic, N. P., & Lalic-Popovic, M. N. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18070793
Texture analysis as a printability tool for pharmaceutical FDM filaments: A review
Tefas, L. R., Bogdan, C., Iovanov, R., Casian, T., Cornilă, A., Achim, M., Tomuță, I., & Iurian, S. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108650 · Cited by 1
Das, S., Singh, P., Pathak, R. K., Das, J., Jana, P., Mahto, B., & Datta, S. (2026) · De Gruyter eBooks · doi:10.1515/9783111719993-004
Applications of 3D Printing in cosmetic industry
Bom, S., Graça, A., Caramona, A., Eddaou, I., Carvalho, M., & Marto, J. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-41499-2.00012-4
Sangave, S. D., Dutta, D., Suryavanshi, P., Deka, M. K., & Banerjee, S. (2026) · Biomedical Materials & Devices · doi:10.1007/s44174-026-00747-5
Iurian, S., Achim, A. M., Rus, L., Șerbu, A.-M., Couți, N., Crișan, A. G., Iovanov, R., Casian, T., Porfire, A. S., & Tomuță, I. (2026) · Processes · doi:10.3390/pr14152411
Turac, I.-R., Casian, T., Iurian, S., Porfire, A. S., Iovanov, R., Popa, D. E., & Tomuță, I. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18080935 · Cited by 1
Phadte, P., Jeedigunta, M. K., Rao, G., & Bothiraja, C. (2026) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-026-00630-0
“By selecting suitable polymers such as polyvinyl alcohol (PVA), hydroxypropyl cellulose (HPC) or Eudragit ® , FDM allows the fabrication of immediate, controlled, or sustained release formulations [23 ].”
A systematic review of 3D printing of pharmaceutical drug products: Barriers and enablers
Gatt, E., Bartolo, N. S., & Azzopardi, L. M. (2026) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2026.115211 · Cited by 1
Shah, S., Parikh, A., Garg, S., & Mehta, T. (2026) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2026.2727678
Anekalla, T. R., Bashetty, S. R., Nalajala, N., Narala, N., Appidi, T., Chakka, L. R. J., & Maniruzzaman, M. (2026) · AAPS PharmSciTech · doi:10.1208/s12249-026-03507-2
“The disappearance of the ACT characteristic peak in PM may be due to a lower % of the drug in the hydrophilic carriers (polymers and plasticizers), which converts the ACT to an amorphous form during heating during DSC testing [44–46].”
Robbani, S., Ilham, T., Arwani, M., Adrinoviarini, Aulia, N. I., Nanda, R. F., Widyaningtyas, S., Vera, V. V., & Silalahi, I. P. (2026) · IOP Conference Series Earth and Environmental Science · doi:10.1088/1755-1315/1653/1/012004
“Additive manufacturing (AM) operates by creating three-dimensional (3D) printed objects in accordance with the desired design (1, 2, 3, 4, 5).”
Influence of infill pattern on ketoprofen release rate from 3D printed buccal films
Panić, J. Č., Todorović, N., Rančić, M., Kalaba, M., Ristić, I., Popović, S. Z., & Lalic-Popovic, M. N. (2026) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2026.2736231
3D Printing of Pharmaceuticals: Quality Assurance Considerations and Regulatory Challenges
More, A. S., Pawar, A. R., Patil, P. S., & Patil, V. V. (2026) · Asian Journal of Research in Chemistry · doi:10.52711/0974-4150.2026.00072
Processing and manufacture of bioplastics
Abedinia, A., Chaleshtori, S. K., Nikmanesh, A., & Hedayatnia, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-41654-5.00010-x · Cited by 2
McKiernan, E. P., Wychowaniec, J. K., Winning, D., Clerkin, S., Martinez‐‐Chauvin, I., Crean, J., Ennis, A., Delaney, C., Florea, L., & Brougham, D. F. (2026) · Small · doi:10.1002/smll.76111
Pharmaceutical applications of 3D printing: drug delivery, discovery, and development
Gorwill, L., Wu, K. Y., Marchand, M., & Tran, S. D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34207-3.00029-0
Liu, Z., Huang, Y., Yanpai, L., Huang, R., Xie, P., Ma, X., Chen, P., & Li, X. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18101330
“In printed dosage forms, polymers serve functions beyond simply acting as carriers for active ingredients [15,60].”
Metadata
- Authors
- Azad, M. A., Olawuni, D., Kimbell, G., Badruddoza, A. Z. M., Hossain, M. S., & Sultana, T.
- Affiliations
- North Carolina Agricultural and Technical State University (US)
- Virginia Commonwealth University (US)
- City University of New York (US)
- Massachusetts College of Pharmacy and Health Sciences (US)
- Corresponding author
- Azad, Mohammad A.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2020-02-03
- Volume
- 12
- Issue
- 2
- Pages
- 124
- ISSN
- 1999-4923 (ISSN-L)
- PMC
- PMC7076526
- OpenAlex
- W3003558240
- Semantic Scholar
- d0e7b174bfd4c9215a0e766bbf1923bb5c15a67d
- Cited by
- 356
- References
- 176
- Citations by year
- 2026: 38 · 2025: 44 · 2024: 48 · 2023: 73 · 2022: 66 · 2021: 57 · 2020: 28
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Pharmaceutics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- CUNY Academic Works (City University of New York) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Physical Sciences › Engineering › Industrial and Manufacturing Engineering › Additive Manufacturing and 3D Printing Technologies
- Physical Sciences › Engineering › Building and Construction › Innovations in Concrete and Construction Materials
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- material extrusion, pharmaceutical 3D printing, fused deposition modeling, polymer rheology, controlled drug release
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.